• Study for Patients with Advanced Non-Small Cell Lung Cancer Worsened by Osimertinib Treatment, Using Selumetinib and Drug Combination

    Not recruiting

    2 1 1 1
    Italy The Netherlands Norway Spain Sweden
  • Study on Early vs. Delayed Ticagrelor with Cangrelor for Patients with STEMI Undergoing PCI

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Italy
  • Study on NTLA-2001 for Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy

    Not recruiting

    1 1 1
    Investigated Diseases:
    France Sweden
  • Study of Talquetamab and Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    1 1 1 1
    Spain
  • Study on Sodium Zirconium Cyclosilicate for Improving Heart Failure Treatment in Patients with High-Risk Hyperkalemia

    Not recruiting

    2 1 1
    Sweden
  • Study of Durvalumab and Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium France Germany Hungary Italy +3
  • Study of venetoclax and azacitidine combination treatment for acute myeloid leukemia patients with measurable residual disease after chemotherapy or before stem cell transplant

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

    Not recruiting

    4 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Cyprus Czechia Denmark +13
  • Study on Reducing Antibiotic Duration for Patients with Complicated Staphylococcus aureus Bacteremia Using Cefazolin Sodium, Flucloxacillin Sodium Monohydrate, and Clindamycin

    Not recruiting

    3 1 1 1
    The Netherlands
  • Study on the Effects of FDY-5301 for Patients with Anterior ST-Elevation Myocardial Infarction (Heart Attack)

    Not recruiting

    3 1
    Investigated Drugs:
    Czechia Germany Hungary Italy The Netherlands Poland +3

powered by